Analyst Ratings For Teligent Inc (NASDAQ:TLGT)
Today, Canaccord Genuity set its price target on Teligent Inc (NASDAQ:TLGT) to $4.00 per share.
There are 2 Hold Ratings, 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Teligent Inc (NASDAQ:TLGT) is Hold with a consensus target price of $7.00 per share, a potential 66.27% upside.
Some recent analyst ratings include
Recent Insider Trading Activity For Teligent Inc (NASDAQ:TLGT)
Teligent Inc (NASDAQ:TLGT) has insider ownership of 22.80% and institutional ownership of 63.36%.
- On 11/13/2017 Carole Ben-Maimon, Director, bought 5,000 with an average share price of $3.48 per share and the total transaction amounting to $17,400.00.
- On 11/10/2017 Steven H Koehler, Director, bought 5,000 with an average share price of $3.62 per share and the total transaction amounting to $18,100.00.
- On 11/9/2017 Stephen Richardson, Insider, bought 6,410 with an average share price of $3.13 per share and the total transaction amounting to $20,063.30.
- On 11/8/2017 Jenniffer Collins, CFO, bought 7,000 with an average share price of $3.04 per share and the total transaction amounting to $21,280.00.
- On 3/11/2016 James C Gale, Director, bought 15,000 with an average share price of $4.91 per share and the total transaction amounting to $73,650.00.
- On 3/11/2016 Jason Grenfell-Gardner, CEO, bought 10,500 with an average share price of $4.82 per share and the total transaction amounting to $50,610.00.
About Teligent Inc (NASDAQ:TLGT)
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's products are used in various applications that range from cosmetics and cosmeceuticals to the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. In addition, it offers contract manufacturing and formulation services. Teligent, Inc. sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.
Recent Trading Activity for Teligent Inc (NASDAQ:TLGT)
Shares of Teligent Inc closed the previous trading session at 4,23 +0,100 2,42 % with 80124 shares trading hands.